Costa A, Court M, Villarino N, Burke N, Mealey K
J Vet Pharmacol Ther. 2020; 44(1):116-125.
PMID: 32744755
PMC: 7819641.
DOI: 10.1111/jvp.12899.
Bteich M
Heliyon. 2019; 5(11):e02879.
PMID: 31844752
PMC: 6895661.
DOI: 10.1016/j.heliyon.2019.e02879.
Koike H, Fujino T, Koike M, Yao S, Shinohara M, Kitahara K
J Arrhythm. 2016; 32(6):468-473.
PMID: 27920831
PMC: 5129116.
DOI: 10.1016/j.joa.2016.03.004.
Anguizola J, Bi C, Koke M, Jackson A, Hage D
Anal Bioanal Chem. 2016; 408(21):5745-5756.
PMID: 27289464
PMC: 4958572.
DOI: 10.1007/s00216-016-9677-7.
Guay D
Clin Pharmacokinet. 2003; 42(14):1243-85.
PMID: 14606931
DOI: 10.2165/00003088-200342140-00004.
The influence of sex on pharmacokinetics.
Schwartz J
Clin Pharmacokinet. 2003; 42(2):107-21.
PMID: 12537512
DOI: 10.2165/00003088-200342020-00001.
Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study.
Borga O, Borga B
J Pharmacokinet Biopharm. 1997; 25(1):63-77.
PMID: 9353694
DOI: 10.1023/a:1025719827072.
Clinical pharmacokinetics of naproxen.
Davies N, Anderson K
Clin Pharmacokinet. 1997; 32(4):268-93.
PMID: 9113437
DOI: 10.2165/00003088-199732040-00002.
Pharmacokinetic optimisation of tricyclic antidepressant therapy.
Furlanut M, Benetello P, Spina E
Clin Pharmacokinet. 1993; 24(4):301-18.
PMID: 8491058
DOI: 10.2165/00003088-199324040-00004.
Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites.
McLachlan A, Cutler D, Tett S
Eur J Clin Pharmacol. 1993; 44(5):481-4.
PMID: 8359187
DOI: 10.1007/BF00315548.
The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers.
Walle U, Fagan T, Topmiller M, Conradi E, Walle T
Br J Clin Pharmacol. 1994; 37(1):21-5.
PMID: 8148214
PMC: 1364704.
DOI: 10.1111/j.1365-2125.1994.tb04233.x.
Changes in the concentration of serum alpha 1-acid glycoprotein in epileptic patients.
Morita K, Yamaji A
Eur J Clin Pharmacol. 1994; 46(2):137-42.
PMID: 8039532
DOI: 10.1007/BF00199877.
Comparison of the serum protein binding of maprotiline and phenytoin in uraemic patients on haemodialysis.
Lynn K, Braithwaite R, Dawling S, Rosser R
Eur J Clin Pharmacol. 1981; 19(1):73-7.
PMID: 7461027
DOI: 10.1007/BF00558388.
Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.
Nyberg G, Axelsson R, MARTENSSON E
Eur J Clin Pharmacol. 1981; 19(2):139-48.
PMID: 7202474
DOI: 10.1007/BF00568401.
Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.
Axelsson R, MARTENSSON E, Alling C
Eur J Clin Pharmacol. 1982; 23(4):359-63.
PMID: 7173306
DOI: 10.1007/BF00613621.
Protein binding of anthraquinone glycosides, with special reference to adriamycin.
Eksborg S, Ehrsson H, Ekqvist B
Cancer Chemother Pharmacol. 1982; 10(1):7-10.
PMID: 7160048
DOI: 10.1007/BF00257228.
Binding of vinblastine to recrystallized human alpha 1-acid glycoprotein.
Steele W, Haughton D, Barber H
Cancer Chemother Pharmacol. 1982; 10(1):40-2.
PMID: 7160043
DOI: 10.1007/BF00257236.
Pethidine binding to blood cells and plasma proteins in old and young subjects.
Holmberg L, Odar-Cederlof I, Nilsson J, Ehrnebo M, BOREUS L
Eur J Clin Pharmacol. 1982; 23(5):457-61.
PMID: 7151852
DOI: 10.1007/BF00605998.
Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.
Nyberg G, MARTENSSON E
Naunyn Schmiedebergs Arch Pharmacol. 1982; 319(3):189-96.
PMID: 7110380
DOI: 10.1007/BF00495864.
Increase of alpha 1-acid glycoprotein after treatment with amitriptyline.
Baumann P, Tinguely D, Schopf J
Br J Clin Pharmacol. 1982; 14(1):102-3.
PMID: 7104160
PMC: 1427590.
DOI: 10.1111/j.1365-2125.1982.tb04942.x.